Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CBD Supplement Market Enforcement Based On FDA Concerns, Not Discretion

May 18 2019

• By Malcolm Spicer

FDA entrance sign 2016

Related Content

FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking

Apr 02 2019

FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps

Apr 03 2019

It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

Jun 25 2018

States Could Take Bloom Off Growth Of CBD Supplement, Food Market

May 08 2019

Additional Topics

United States US States Dietary Supplements FDA Compliance Advertising, Marketing & Sales Business Strategies Commercial Ingredients Manufacturing Legislation Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.